Publications
News
-
13 January 2025
The Global IP Matrix magazine published an article “Adventures of Extension” by Vladimir Biriulin, Partner, Russian Patent Attorney and Elena Nazina, Partner, Russian Patent Attorney, Eurasian Patent Attorney, Head of Сhemical & Life Science Department (both - Gorodissky & Partners, Moscow).
All News
Publications
-
13 January 2025
Pharmaceutical products must go through research, clinical trials, and registration with the health ministry or other authorised government bodies, before going to the public. This multi-tiered composite procedure gave birth to extending the term of patents directed to pharmaceutical products up to 25 years in many jurisdictions. Circumstances surrounding such cases may present difficulties to the patent owner.
All Publications
«Gorodissky» in media
-
3 February 2021
Sergey Medvedev, Partner at Gorodissky & Partners, gave the following comment to Practical Law by Thomson Reuters on what to expect in 2021 in Pharma: “The use of the patented technologies and inventions for the benefit of national security in the pharma sphere should become a hot issue. The Russian government has already issued a binding order under Article 1360 of the Russian Civil Code to allow the use of inventions related to the production of Remdesivir...
All «Gorodissky» in media
Events
-
Evgeniya Smolnikova, Trademark Attorney, Senior Lawyer (Gorodissky & Partners, Moscow) will speak on ‘Early termination of trademark protection after three years of non-use: what to expect in 2025?’ at the meeting «Legal Risk Management in 2025» of the Committee on Legal Affairs of the CCI France Russie.
All Events
G-newsletters
Legal updates
-
Starting October 5, 2024 the amendments to the Regulations on Patent and Other Fees of the Russian PTO approved by Decree of the Government of the Russian Federation No. 1278 dated September 18, 2024, came into effect.
All Legal updates
